文献速递脑血管病外科神经重症

脑脊液白细胞介素6作为重型蛛网膜下腔出血后血管痉挛与脑室炎发病的生物标志物

Interleukin 6 in the Cerebrospinal Fluid as a Biomarker for Onset of Vasospasm and Ventriculitis After Severe Subarachnoid Hemorrhage.
PubMed 文献 · World Neurosurg · 2016-12-05

研究纳入63例连续动脉瘤性蛛网膜下腔出血并外引流患者,检测血清和脑脊液白细胞介素6等可溶性标志物,评估其对脑性血管痉挛和外引流相关脑室炎的早期诊断价值,并与无并发症的动脉瘤性蛛网膜下腔出血区分。结果显示脑脊液白细胞介素6在脑室炎起病时显著升高,对区分脑室炎与无并发症患者具有极好诊断潜力。

要点

  • 脑脊液白细胞介素6在脑室炎起病时均值±标准差为7588±4580 pg/mL,显著高于无并发症患者的234±239 pg/mL。
  • 脑脊液白细胞介素6区分脑室炎与无并发症患者曲线下面积1.00,截断值707,灵敏度100%,特异度100%。
  • 脑脊液白细胞介素6区分脑室炎与脑性血管痉挛曲线下面积0.757,截断值3100 pg/mL,灵敏度86.7%,特异度70.6%。

核心结论

  • 动脉瘤性蛛网膜下腔出血后发生脑性血管痉挛或脑室炎的患者脑脊液白细胞介素6升高,脑脊液白细胞介素6高于截断值3100 pg/mL的患者脑室炎可能性增加,介于530至3100 pg/mL的患者脑性血管痉挛检验后概率增加。

研究设计与样本

  • 研究连续纳入63例动脉瘤性蛛网膜下腔出血并外引流的患者,检测血清和脑脊液中白细胞介素6等可溶性标志物浓度。

主要发现

  • 临床病程包括27例脑性血管痉挛、17例脑室炎和19例无并发症的动脉瘤性蛛网膜下腔出血。
  • 脑脊液白细胞介素6均值±标准差在脑室炎起病时为7588±4580 pg/mL,脑性血管痉挛为4102±4970 pg/mL,无并发症患者为234±239 pg/mL,P<0.001。
  • 脑脊液白细胞介素6区分脑室炎与无并发症患者曲线下面积1.00,截断值707,灵敏度100%,特异度100%。
  • 脑脊液白细胞介素6区分脑室炎与脑性血管痉挛曲线下面积0.757,截断值3100 pg/mL,灵敏度86.7%,特异度70.6%。
  • 脑性血管痉挛组脑脊液白细胞介素6浓度较无并发症组显著升高,曲线下面积0.937,截断值530 pg/mL,灵敏度87.5%,特异度91.7%。

关键数值与推荐

  • 脑脊液白细胞介素6高于截断值3100 pg/mL提示脑室炎可能性增加。
  • 脑脊液白细胞介素6在530至3100 pg/mL之间提示脑性血管痉挛检验后概率增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of the study was to investigate the diagnostic potential of interleukin 6 (IL-6) and other soluble biomarkers in serum and cerebrospinal fluid (CSF) for early diagnosis of cerebral vasospasm (cVSSAH) and external ventricular drain-associated ventriculitis (VCSAH) and to separate these conditions from aneurysmal subarachnoid hemorrhage (aSAH) without further complication (SAHw/o/c). METHODS: The concentrations of serum biomarkers and markers in the CSF were collected in 63 consecutive patients with aSAH and external ventricular drainage. Arithmetical means and standard deviations, area under the curve (AUC), cutoff values (C-OFF), sensitivity (SE), and specificity (SP) were calculated for markers and their correlation with SAHw/o/c, cVSSAH, and VCSAH. RESULTS: Clinical courses included 27 patients with cVSSAH, 17 with VCSAH, and 19 with SAHw/o/c. Mean ± standard deviationCSFIL-6 values were 7588 ± 4580 pg/mL at onset of VCSAH and 4102 ± 4970 pg/mL for cVSSAH and higher than 234 ± 239 pg/mL in SAHw/o/c (P < 0.001). CSFIL-6 showed excellent diagnostic potential for differing between VCSAH and SAHw/o/c (AUC, 1.00; C-OFF, 707; SE, 100%; SP, 100%), and a moderate diagnostic potential for differing VCSAH from cVSSAH (AUC, 0.757; C-OFF, 3100 pg/Ml; SE, 86.7%; SP, 70.6%). The concentration of CSFIL-6 within the cVSSAH group was significantly increased compared with SAHw/o/c (AUC, 0.937; C-OFF, 530 pg/mL; SE, 87.5%; SP, 91.7%). CONCLUSIONS: CSFIL-6 is increased after aSAH in patients with cVSSAH or VCSAH. Patients with a CSFIL-6 level higher than a C-OFF of 3100 pg/mL have an increased likelihood for VCSAH; patients with CSFIL-6 levels between 530 and 3100 pg/mL have an increased posttest probability for cVSSAH.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lenski M, Huge V, Briegel J, et al. Interleukin 6 in the Cerebrospinal Fluid as a Biomarker for Onset of Vasospasm and Ventriculitis After Severe Subarachnoid Hemorrhage. World Neurosurg. 2016. PMID: 27931942. doi:10.1016/j.wneu.2016.11.131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。